In this video, Seth P. Lerner, MD, FACS, discusses current and projected advances in genomic testing for bladder cancer, which were topics he focused on in his recent presentation at the 2021 Society of Urologic Oncology Annual Meeting. Lerner is a professor of urology, Beth and Dave Swalm Chair in urologic oncology, director of urologic oncology, and director of the Multidisciplinary Bladder Cancer Program at the Baylor College of Medicine, Houston, Texas.
Study identifies 11 gene mutations linked to aggressive prostate cancer
October 3rd 2023This is the largest prostate cancer study that examined the exome, according to the researchers, who believe their findings can potentially inform the makeup of panels used for genetic testing in prostate cancer.
2 Clarke Drive
Cranbury, NJ 08512